Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

November 25th 2015

Diabetes in children & young people (NICE 2015)

Given the epidemiology of diabetes, most Health Care Professionals spend a significant amount of time treating Type 2 adult patients, often at the expense of a very vulnerable group of patients, specifically young people. The epidemiology of diabetes in this group is also changing as, due to the rise in obesity, it is increasingly common to see a young person with Type 2 diabetes. As a result, it is timely that NICE has published guidance for this group of patients, an update from their original 2004 document. In fact, early in their guidance, the possibility of Type 2 diabetes is raised at time of diagnosis in certain groups including patients of S Asian origin or show signs of insulin resistance (e.g. acanthosis nigricans). There is also increasing recognition of different sub types of diabetes e.g. monogenic with advice around genetic testing and C-peptide measurement. Whilst most children will be managed in secondary care, there are several developments within this guidance which will impact on service delivery. Specifically, this includes enhanced patient (and family) education, a requirement to attend clinic 4 times per year as well as further advice on retinal screening. There is some advice on transition from paediatric to adult care although given the importance of this period, guidance is surprisingly brief especially the potential benefits of psychological services in diabetes care. The lack of recommendations about transition contrasts with the large detailed description on ketoacidosis management, despite DKA guidance being a summary of recommendations from the Joint British Diabetes Societies.

Unsurprisingly, the main sections refer to glycaemic control including targets and drug use. An HbA1c<48mmol/mol (6.5%) is recommended and although an individualised target is suggested, special reference is given to those whose HbA1c is>53mmol/mol. Glycaemic targets have been divided into the management of both T1 and T2 patients. For both, a patient centred approach is advised but a basal bolus regimen is recommended as first line with pump therapy another early option especially if good control is not possible. Obviously dietary modification including carbohydrate counting is required – assuming dietetic services are adequate. As a contrast to T1 management in adults, Metformin is not recommended due to lack of evidence yet the sustained release preparation is considered first line in children with T2 diabetes.  Guidelines for this group of patients are the most significant change since 2004 in recognition of their growing number with extensive advice given about lipid, blood pressure and renal complications.

Overall, this new and updated guidance in an important patient group from NICE is welcome however, as ever, the challenge will be its implementation especially those sections where funding and service delivery need addressing.

Dr Mark Freeman

October 2015

Categories: Updates

Diabetes Updates Archive

calendar-iconDiabetes Updates Archive ››

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Napp DiabetesAstraZenecaBoehringer IngelheimNovo Nordisk

Silver Sponsors

About Ascensia Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership